Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Author:

Patel Shreyaskumar1,von Mehren Margaret2,Reed Damon R.3ORCID,Kaiser Pamela4,Charlson John5,Ryan Christopher W.6,Rushing Daniel7,Livingston Michael8,Singh Arun9,Seth Rahul10,Forscher Charles11,D'Amato Gina12,Chawla Sant P.13,McCarthy Sharon14,Wang George14,Parekh Trilok14,Knoblauch Roland14,Hensley Martee L.15,Maki Robert G.16ORCID,Demetri George D.17

Affiliation:

1. The University of Texas MD Anderson Cancer Center Houston Texas

2. Fox Chase Cancer Center Philadelphia Pennsylvania

3. Moffitt Cancer Center Tampa Florida

4. Lutheran General Advanced Care Center Park Ridge Illinois

5. Medical College of Wisconsin Milwaukee Wisconsin

6. Knight Cancer Institute Oregon Health and Science University Portland Oregon

7. Simon Cancer Center Indiana University Indianapolis Indiana

8. Blumenthal Cancer Center Carolinas HealthCare System Charlotte North Carolina

9. UCLA Medical Center Los Angeles California

10. SUNY Upstate University Hospital Syracuse New York

11. Cedars‐Sinai Medical Center Los Angeles California

12. Georgia Cancer Specialists Northside Hospital Cancer Institute Atlanta Georgia

13. Sarcoma Oncology Center Santa Monica California

14. Janssen Research & Development, LLC Raritan New Jersey

15. Memorial Sloan Kettering Cancer Center New York New York

16. Mount Sinai Medical Center New York New York

17. Center for Sarcoma and Bone Oncology, Dana‐Farber Cancer Institute and Ludwig Center at Harvard Harvard Medical School Boston Massachusetts

Funder

Janssen Research & Development, LLC

Memorial Sloan Kettering Cancer Center

Ludwig Center

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3